Format

Send to

Choose Destination
See comment in PubMed Commons below
Rev Alerg Mex. 2017 Jul-Sep;64(3):371-375.

[Solar urticaria. Case report and literature review].

[Article in Spanish; Abstract available in Spanish from the publisher]

Author information

1
Universidad de Antioquia, IPS Universitaria, Grupo de Alergología Clínica y Experimental, Medellín, Colombia. jotamsc@yahoo.co.

Abstract

in English, Spanish

BACKGROUND:

Solar urticaria is a rare type of inducible urticaria characterized by wheal and erythema formation shortly after exposure to sunlight or to an artificial light source; its pathophysiology is not yet entirely understood. The treatment of choice, in addition to exposure avoidance, consists in antihistamine administration.

CLINICAL CASE:

This is the case of a 27-year-old woman with no personal history of allergic diseases and with a 2-year history of erythema and wheals in photo-exposed areas associated with sunlight exposure for periods longer than 10 minutes. A provocation test was carried out; she was started on fexofenadine at 4-fold the standard dose (720 mg/day). Six weeks later, a new challenge was carried out without the antihistamine being discontinued; the reaction was less severe, but she continued with erythema for the first 60 minutes post-exposure. After 3 months on high-dose antihistamines, she referred marked improvement in her quality of life and tolerance to brief sunlight exposure (for less than 15 minutes).

CONCLUSIONS:

Solar urticaria is a rare process but with a high impact on the patient. The use of antihistamines partially relieves symptoms and allows better tolerance to lighting expositions.

KEYWORDS:

Antihistamines; Foto-test; Fotosensibility; Solar urticaria

PMID:
29046033
DOI:
10.29262/ram.v64i3.202
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center